Colchicine in Acutely Decompensated HFREF

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2028

Conditions
Heart FailureDecompensated Heart FailureHeart Failure With Reduced Ejection Fraction
Interventions
DRUG

Colchicine 0.6 mg

Colchicine treated subjects will take 0.6mg of drug 2x per day (1 time if kidney disease is present) for 14 days, then will take 0.6mg of drug 1x per day (or every other day if kidney disease is present) for 76 +/1 days.

DRUG

Control/Placebo group

Placebo treated subjects will take 0.6mg of placebo 2x per day (1 time if kidney disease is present) for 14 days, then will take 0.6mg of placebo1x per day (or every other day if kidney disease is present) for 76 +/1 days.

Trial Locations (1)

22908

RECRUITING

UVA Health, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER